Helping compensate for the funding shortfall is the Novo Nordisk Foundation, which has pledged up to 380 Danish kroner ($58 ...

Dividend growth and low payout ratios are key for long-term compounding. Click here for more information on Dividend ...

Lazard acted as the exclusive financial advisor to Paratek Pharmaceuticals, and Skadden, Arps, Slate, Meagher & Flom LLP served as its legal advisor. Evercore acted as the exclusive financial advisor ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

In this exclusive interview, Queen Latifah opens up about being told to lose weight on “Living Single,” the end of “The ...

BMO Capital Markets reaffirmed its “Market Perform” rating and $64.00 price target for Novo Nordisk A/S (NYSE:NVO) following the announcement of a CEO transition. Analysts view the leadership change ...

European equity markets may thrive with monetary easing, fiscal expansion, and controlled inflation, despite risks from ...

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

Australia's central bank has cut interest rates to a two-year low as cooling inflation... Xeinadin, the professional services firm, has announced the acquisition of KBG Accountants... DUBLIN The Iseq ...

Honda Motor has been scaling back its investment in electric vehicles (EVs) given... The operator of Milan’s tram system is one of two European transport providers... Some doubt has been cast on the ...

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...